Introduction Interstitial lung disease (ILD) is a frequent manifestation of connective tissue
disease (CTD) with substantial variability in prevalence and outcomes reported across CTD …

Interstitial lung disease (ILD) has been recognized as a frequent manifestation associated
with a substantial morbidity and mortality burden in patients with autoimmune rheumatic …

Background Pulmonary disease is a potentially serious yet underdiagnosed complication of
Sjögren's syndrome, the second most common autoimmune rheumatic disease …

Lung involvement, especially interstitial lung disease, is a potentially severe extra-glandular
manifestation of Primary Sjogren's Syndrome (pSS-ILD). ILD can manifest either as a late …

Interstitial lung disease (ILD) is a relatively frequent manifestation of systemic autoimmune
rheumatic disorders (SARDs), including systemic sclerosis (SSc), rheumatoid arthritis (RA) …

Extraglandular manifestations (EGMs) in primary Sjogren's syndrome (pSS) represent the
clinical expression of the systemic involvement in this disease. EGMs are characterized by a …

Objectives Interstitial lung disease (ILD) is an important manifestation of autoimmune
diseases that can lead to morbidity and mortality. Although several autoantibodies have …

An understanding of the characteristics of ILD in SjS, MCTD, and SLE is important for the
pulmonary specialist. Future research should identify risk factors for progression and …

Objective To identify clinical characteristics and risk factors related to the progression of
interstitial lung disease (ILD) in patients with primary Sjögren's syndrome (pSS). Methods In …

Objectives To explore clinical and laboratory characteristics of primary Sjögren's syndrome
(pSS) complicated with interstitial lung disease (ILD) and investigate the risk factors for …